S

Sutro Biopharma
D

STRO

2.68000
USD
0.08
(2.88%)
مغلق
حجم التداول
34,744
الربح لكل سهم
-3
العائد الربحي
-
P/E
-2
حجم السوق
220,989,383
الأخبار

العنوان: Sutro Biopharma

القطاع: Healthcare
الصناعة: Biotechnology
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancerand autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.